KUANO
Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
KUANO
Industry:
Artificial Intelligence Biotechnology
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.kuano.ai
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Content Delivery Network Euro Google Apps For Business Typekit LocalBusiness Schema Squarespace
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Arctoris
Arctoris is a tech-enabled platform company in biotechnology, combining robotics & data science to accelerate drug discovery.
Emedgene
Emedgene provides data-driven AI solutions for genomic diagnostics and discovery at scale.
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Current Employees Featured
Founder
Investors List
O2h Ventures
O2h Ventures investment in Seed Round - Kuano
ACF Investors
ACF Investors investment in Seed Round - Kuano
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Kuano
Innovate UK
Innovate UK investment in Grant - Kuano
Official Site Inspections
http://www.kuano.ai
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Kuano"
About Us - Kuano
About Kuano Kuano is revolutionising the way drugs are designed and prioritised, accelerating life-saving discoveries, creating better outcomes and generating savings. A unique fusion of drug hunting and technology expertise allows us to …See details»
Kuano - Crunchbase Company Profile & Funding
Kuano may be growing as it has successfully raised significant seed funding, which is a strong indicator of investor confidence and financial resources for …See details»
Pipeline — Kuano
At Kuano, we envision a world where breakthroughs in modelling chemistry rapidly translate into accessible, effective treatments that improve lives globally. By harnessing cutting-edge …See details»
Kuano Company Profile 2024: Valuation, Funding
Kuano General Information Description. Developer of a quantum mapping and AI-based discovery platform designed to offer assistance for drug discovery and …See details»
Kuano Company Profile: Overview and Full News Analysis
Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, announced the close of its 1.8M seed funding round . The investment …See details»
Kuano - Company Profile - Tracxn
Jan 1, 2025 Kuano - Provider of AI and quantum services for molecular design. Raised a total funding of $3.63M over 2 rounds from 8 investors. Founded by Vid Stojevic and David Wright …See details»
Kuano Company Information - Funding, Investors, and More
Kuano, based in London, offers a quantum simulation platform aimed at transforming drug discovery for biotech and health tech companies. Their B2B, SaaS model provides faster and …See details»
Kuano.ai Company Profile - Office Locations, Competitors ... - Craft
Kuano.ai is a provider of innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to …See details»
Kuano raises closes £1.8M harnessing quantum mechanics and AI …
Sep 12, 2023 Today drug discovery company Kuano, announced the close of a £1.8 million seed funding round. The company combines quantum mechanics with AI to design the next …See details»
Kuano closes £1.8M seed funding round to validate …
Sep 13, 2023 Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, today announced the close of its £1.8M seed funding round, led by Mercia Ventures ...See details»
Kuano Company Profile Funding & Investors | YourStory
Kuano’s approach is to combine state-of-the-art simulation and AI to add quantum detail to structure based drug discovery. BioTech/BioPharmaceutical Claim ProfileSee details»
Kuano - Leadership Team - The Org
The Leadership Team at Kuano drives the strategic vision and operational execution of the company's innovative quantum and AI solutions for drug discovery. Comprising the CEO, CTO …See details»
Quantum drug discovery platform raises £1.8m - Mercia
Sep 13, 2023 Kuano, a drug discovery company combining quantum mechanics with AI to design the next generation of medicines, has closed a £1.8m seed funding round led by …See details»
Computational chemistry and AI create a quantum leap in drug …
Nov 11, 2022 UK-based startup Kuano is using computing advancements in biomolecular simulation and artificial intelligence to add quantum detail to structure-based drug discovery, …See details»
About Us (Copy) — Kuano
Kuano's novel approach exploiting quantum mechanics has unlocked a unique target that permits an exciting biologically effective novel therapy for a much larger proportion of cancer sufferers” …See details»
Kuano - GitHub
Kuano-ai/docker-similarity-codes’s past year of commit activity. Dockerfile 0 0 0 0 Updated Nov 9, 2024. SimpleMol Public Simple class and examples for handling molecules as basic python …See details»
Introducing CoreAI – Platform and Tools - The Official Microsoft …
2 days ago To more rapidly and boldly advance our roadmap across each of these layers, we are creating a new engineering organization: CoreAI – Platform and Tools. ... This new …See details»
Kuano raises £1.8M in seed funding round to accelerate quantum …
Sep 12, 2023 Kuano is an artificial intelligence company using quantum simulations to create molecular design solutions to challenging enzyme targets. Enzymes represent the largest …See details»
Palo Alto Networks Channel Chief On Why AI, Platformization Go …
21 hours ago At the same time, as AI has rapidly become a top priority for many organizations, Palo Alto Networks is seeking to show how its array of GenAI-powered capabilities actually go …See details»
Turbocharging Organizational Learning With GenAI - MIT Sloan …
2 days ago Combined with traditional AI, generative AI expands the scope of potential improvement in many processes and decisions and the ease with which this new knowledge …See details»